Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wadih Arap

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|July 12, 2008
Quality of life and satisfaction with outcome among prostate-cancer survivorsWadih Arap
Cancer Cell|May 18, 2004
Engineered embryonic endothelial progenitor cells as therapeutic Trojan horsesWadih Arap, Renata Pasqualini
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2003
Hybridoma-free generation of monoclonal antibodiesRenata Pasqualini, Wadih Arap
Trends in Cardiovascular Medicine|March 21, 2006
Vascular targeting: recent advances and therapeutic perspectivesAmin Hajitou, Renata Pasqualini, Wadih Arap
Expert Opinion on Therapeutic Targets|February 25, 2009
Targeting the extracellular signature of metastatic colorectal cancersSerena Marchiò, Wadih Arap, Renata Pasqualini
Methods in Enzymology|November 22, 2008
Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptidesMartin Trepel, Renata Pasqualini, Wadih Arap
Journal of the National Cancer Institute|May 27, 2026
Premature termination of early-phase cancer clinical trials: "It's the economy, stupid!"Wadih Arap, Shridar Ganesan, Renata Pasqualini
Oncology (Williston Park, N.Y.)|December 18, 2007
Molecular targets on blood vessels for cancer therapies in clinical trialsMasanori Sato, Wadih Arap, Renata Pasqualini
Current Opinion in Chemical Biology|May 23, 2002
In vivo phage display and vascular heterogeneity: implications for targeted medicineMartin Trepel, Wadih Arap, Renata Pasqualini
Expert Opinion on Drug Discovery|March 14, 2013
Ligand-directed profiling: applications to target drug discovery in cancerFernanda I Staquicini, Renata Pasqualini, Wadih Arap
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|July 12, 2008
Quality of life and satisfaction with outcome among prostate-cancer survivorsWadih Arap
Cancer Cell|May 18, 2004
Engineered embryonic endothelial progenitor cells as therapeutic Trojan horsesWadih Arap, Renata Pasqualini
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2003
Hybridoma-free generation of monoclonal antibodiesRenata Pasqualini, Wadih Arap
Trends in Cardiovascular Medicine|March 21, 2006
Vascular targeting: recent advances and therapeutic perspectivesAmin Hajitou, Renata Pasqualini, Wadih Arap
Expert Opinion on Therapeutic Targets|February 25, 2009
Targeting the extracellular signature of metastatic colorectal cancersSerena Marchiò, Wadih Arap, Renata Pasqualini
Methods in Enzymology|November 22, 2008
Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptidesMartin Trepel, Renata Pasqualini, Wadih Arap
Journal of the National Cancer Institute|May 27, 2026
Premature termination of early-phase cancer clinical trials: "It's the economy, stupid!"Wadih Arap, Shridar Ganesan, Renata Pasqualini
Oncology (Williston Park, N.Y.)|December 18, 2007
Molecular targets on blood vessels for cancer therapies in clinical trialsMasanori Sato, Wadih Arap, Renata Pasqualini
Current Opinion in Chemical Biology|May 23, 2002
In vivo phage display and vascular heterogeneity: implications for targeted medicineMartin Trepel, Wadih Arap, Renata Pasqualini
Expert Opinion on Drug Discovery|March 14, 2013
Ligand-directed profiling: applications to target drug discovery in cancerFernanda I Staquicini, Renata Pasqualini, Wadih Arap
Pageof 25